DePaul Community Health Centers’ (DCHC) Infant Equity Education Program (DIEEP) is awarding 10 small businesses in Orleans Parish a $1,000 grant to assist in complying with the Providing Urgent Maternal Protection for Nursing Mothers (PUMP) Act, which mandates that all employers provide reasonable, paid break times for employees to express milk in a private, non-bathroom space. Applications are due on or before Friday, Aug.
August 6, 2024
Newsweek has named St. Tammany Health System’s flagship St. Tammany Parish Hospital one of the best hospitals in America and the fourth-best hospital in the state of Louisiana, according to its recently released 2024 rankings.
It is the only Northshore hospital and one of only 17 Louisiana hospitals to make the list.
August 6, 2024
M. A. “Tonette" Krousel-Wood, MD, the Jack Aron Chair in Primary Care Medicine and the director of the Center for Health Outcomes, Implementation and Community Engaged Sciences (CHOICES) at Tulane University, and Franck Mauvais-Jarvis, MD, director of Tulane's Center of Excellence in Sex-Based Biology & Medicine, will use the grant to investigate how differences in sex and gender can impact health outcomes and shape new treatments. The COBRE will fund a wide spectrum of innovative research involving investigators from across the university.
July 30, 2024
An experimental drug originally developed to treat cancer may help clear HIV from infected cells in the brain, according to a new Tulane University study.
For the first time, researchers at Tulane National Primate Research Center found that a cancer drug significantly reduced levels of SIV, the nonhuman primate equivalent of HIV, in the brain by targeting and depleting certain immune cells that harbor the virus.
July 30, 2024
LSU Health New Orleans announced the publication of a groundbreaking study led by Giulia Monticone, PhD, in the prestigious journal EMBO Reports.
The study’s publication is live at https://doi.org/10.1038/s44319-024-00189-4.
This study unveils that the antiviral effects of the COVID-19 drug remdesivir are primarily due to a novel immunological mechanism rather than direct antiviral activity.
- ‹ previous
- 18 of 575
- next ›